arrow
M

Minoru Kanaya

sapporo city general hospital
H指数:11
被引数:618

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort study

费城染色体阴性但BCR::ABL1阳性急性淋巴细胞白血病:一项真实世界多中心队列研究

2026-01-010
PRE
Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia

异基因造血干细胞移植治疗获得性纯红细胞再生障碍的结局

2025-12-010
PRE
Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era

血液系统疾病中的严重和/或持续COVID-19:奥密克戎时代前及期间的临床意义

2025-11-050
OA
Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia

易丢失的HLA I类等位基因揭示了获得性再生障碍性贫血早期造血细胞移植的结局

2025-09-050
PRE
Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine–venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net

与第一周期阿扎胞苷-维奈克拉组合中14天、21天或标准28天维奈克拉治疗相比,在未经治疗的急性髓系白血病中具有可比的结果:来自北海道白血病网的现实世界经验

2025-07-030
OAAI
FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML

FLT3抑制剂和造血干细胞移植可延长FLT3-ITD-positive AML患者的生存期

2024-11-301
PRE
Evaluation of Venetoclax Duration in Venetoclax-Azacitidine Regimen for Untreated Acute Myeloid Leukemia: Real World Experience from Hokkaido Leukemia Net

评估Venetoclax持续时间在Venetoclax-Azacitidine方案中对初治急性髓系白血病的影响:来自Hokkaido Leukemia Net的真实世界经验

BLOOD
IF23.1
2024-11-051
PRE
Combination of Low White Blood Cell Count and Impaired Renal Function Is a Risk Factor for Higher Concentrations of Venetoclax and Prolonged Neutropenia in AML Patients with Venetoclax Combined Regimen: Real World Experience in the Japanese Cohort

低白细胞计数与肾功能受损的组合是接受维奈克拉联合方案治疗的AML患者维奈克拉浓度升高及中性粒细胞减少症持续时间延长的一项风险因素:日本队列的真实世界经验

BLOOD
IF23.1
2024-11-050
PRE
Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia

成人再生障碍性贫血患者异基因造血干细胞移植前中性粒细胞绝对计数的意义

2024-05-162
PRE
Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia

单倍体相合干细胞移植后环磷酰胺与脐血移植治疗再生障碍性贫血的比较

2023-12-015
PRE
Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires
2023-08-113
OAAI
Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
2023-01-121
OAAI
Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
2022-11-0120
OAAI
Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil
2022-10-052
PRE